Frequently Asked Questions
What exchange is Medwell Capital listed on and what is your stock symbol?
Medwell Capital is listed on the Toronto stock exchange (TSX) under the symbol MWC.
How do I request an Annual Report?
Please click here to request an annual report.
Can I purchase shares directly through the company?
No, Medwell Capital does not a have a direct stock purchase plan.
Who is the registrar and transfer agent for Medwell Capital?
Computershare
510 Burrard Street
Vancouver, B.C.
Phone: (604) 661-9400
Who is the auditor for Medwell Capital?
PricewaterhouseCoopers LLP
How many employees does Medwell Capital have and are you recruiting?
Medwell Capital currently has approximately 15 employees and we are not recruiting at this time.
What is the history of Medwell Capital?
Medwell Capital was formally named Medwell Capital Corp. Medwell Capital was a biotechnology company focused on advancing dirucotide, a product for multiple sclerosis. BioMS raised over $180 million for the project and partnered the drug with Eli Lilly and Company in 2007. In 2010, the Company decided to implement a new corporate strategy and identity – the new name Medwell Capital Corp. was approved by shareholders on June 25, 2010. Today, Medwell Capital is a service provider in the healthcare industry.
What is the current status of dirucotide?
The Company has completed its substantive review of the data from the discontinued late-stage trials for dirucotide, its drug candidate for the treatment of multiple sclerosis (MS). It has been decided that it will explore a compassionate access and research program with limited financial commitment, but that it will not pursue further late stage clinical trials with dirucotide in MS.
Who can I call if I have further questions?
For general enquires please call 1-780-413-7152 or email: info@medwellcapital.com